MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 

Location: Categories / Business / Industries / Medical

Magazine articles on health care providers, pharmaceutical companies, and medical technology.
Old Articles: <Older 5641-5650 Newer>
BusinessWeek
May 20, 2009
Maria Bartiromo
Pfizer's Kindler on Health-Care Reform and the Wyeth Deal Pfizer's CEO discusses its acquisition of Wyeth and its plan to provide some drugs for free to those without jobs and insurance. mark for My Articles 1254 similar articles
BusinessWeek
May 20, 2009
Catherine Arnst
Health-Care Reform: Who Pays Is So Taboo Neither Congress nor the White House will endorse any of the options: raise taxes, ration care, or cut payments to doctors, hospitals, and drugmakers. mark for My Articles 321 similar articles
The Motley Fool
May 20, 2009
Brian Orelli
Clinical Trial Positive, Stock Not So Much Isis and Genzyme hit a homer with their cholesterol drug, mipomersen, but they'll need another big play to win the game. mark for My Articles 161 similar articles
The Motley Fool
May 20, 2009
Brian Orelli
Johnson & Johnson Tries to Pull a Travolta Johnson & Johnson seems to be making a comeback, after its drug-eluting stent market share fell precipitously to just 15% in the first quarter. mark for My Articles 465 similar articles
The Motley Fool
May 20, 2009
Brian Orelli
Joining to Treat, and Beat, Diabetes Medical-device maker Medtronic and drugmaker Eli Lilly are teaming up to co-promote the companies' diabetes products to doctors and patients. mark for My Articles 444 similar articles
The Motley Fool
May 19, 2009
Alex Dumortier
Is This 14.4% Annualized Return Risk-Free? A merger arbitrage that looks relatively low-risk. mark for My Articles 256 similar articles
The Motley Fool
May 19, 2009
Brian Orelli
The Cherry on Pfizer's Acquisition Sundae Pfizer may inherit a lawsuit. mark for My Articles 314 similar articles
The Motley Fool
May 19, 2009
Brian Orelli
Flip-Flopping: Not Just for Politicians Anymore The FDA's change is good for companies. mark for My Articles 386 similar articles
The Motley Fool
May 19, 2009
Brian Orelli
Medtronic Gets Whacked, Seeks Recovery Device Medtronic gets hammered on lackluster guidance. mark for My Articles 194 similar articles
The Motley Fool
May 18, 2009
Brian Orelli
Is There Life After 600% Returns? Just because a drug company gets a massive increase in the stock price after a positive clinical trial or an FDA approval, that doesn't mean all the growth is completely factored into the stock price. mark for My Articles 1038 similar articles
<Older 5641-5650 Newer>    Return to current articles.